Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06664697 · ClinicalTrials.gov registry record
Post-Market Clinical Investigation of the IotaSOFT Insertion System
A clinical trial of Hearing Loss, Sensorineural and Cochlear Implantation, sponsored by iotaMotion.
- Recruiting
- Registry status
- 50
- Enrollment target
- 3
- Study locations
NCT06664697: Recruiting study of Hearing Loss, Sensorineural and Cochlear Implantation, sponsored by iotaMotion.
NCT06664697 is a study of Hearing Loss, Sensorineural and Cochlear Implantation that is actively recruiting participants, run by iotaMotion. The registered enrollment target is 50 participants, below the 784-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (94% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06664697, a study of Hearing Loss, Sensorineural and Cochlear Implantation, is actively recruiting participants, sponsored by iotaMotion.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of the proposed study is to evaluate the continued safety of the iotaSOFT Insertion System when used by a surgeon to assist with inserting a CI electrode array in one ear per subject
Primary Outcome
Number of Subjects Experiencing a Serious or Related Adverse Event Due to Use of the iotaSOFT Insertion System During Cochlear Implant Surgery through 1 month post-operative follow-up
Conditions Studied
Interventions
- DEVICE Cochlear Implantation with Robotic-Assisted Insertion System
Study Locations (3)
Indiana
- Indiana University - Indianapolis
Iowa
- University of Iowa - Iowa City
Oregon
- Oregon Health and Sciences University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2025-12-31 |
What NCT06664697 shows while recruiting
NCT06664697 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 784-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (94% lower).
The record links to 3 conditions, with Hearing Loss, Sensorineural appearing as the primary indexed condition, and to 1 intervention - of which Cochlear Implantation with Robotic-Assisted Insertion System is the first listed.
NCT06664697 reports a single indexed study location in Indiana, Iowa, Oregon.
Frequently Asked Questions
What is clinical trial NCT06664697 about?
NCT06664697 is a clinical study titled "Post-Market Clinical Investigation of the IotaSOFT Insertion System". The purpose of the proposed study is to evaluate the continued safety of the iotaSOFT Insertion System when used by a surgeon to assist with inserting a CI electrode array in one ear per subject
What is the current status of trial NCT06664697?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2024-10-01. Estimated completion is 2025-12-31.
What conditions does trial NCT06664697 study?
This clinical trial studies the following conditions: Hearing Loss, Sensorineural, Cochlear Implantation, Hearing Loss, Cochlear.
What interventions are being tested in trial NCT06664697?
The interventions under investigation include: Cochlear Implantation with Robotic-Assisted Insertion System (DEVICE).
Who is sponsoring clinical trial NCT06664697?
This trial is sponsored by iotaMotion, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06664697 being conducted?
This trial has 3 study locations across Indiana, Iowa, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss, Sensorineural
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06664697's enrollment target sits among peer trials
50 9th of 20 higher than 9 of 20 other Hearing Loss, Sensorineural trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hearing Loss, Sensorineural trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
RECRUITING · NA
-
Barriers and Facilitators to OTC Hearing Aids Success
RECRUITING · NA
-
Preschool Hearing Screening
RECRUITING · NA
-
Listening Effort in Cochlear Implant Users
RECRUITING · NA
-
Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia
RECRUITING · NA
-
Reading Outcomes in Children With Vestibular Loss
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI